Rheumatology Journals

Rheumatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Puig JG et al. - Clinicians should be aware of the presence of metabolic syndrome in patients with hyperuricemia or gout in order to control its components (high blood pressure, obesity, etc.) and hence reduce the risk for cardiovascular disease. Long-term, randomized interventional clinical trials are needed to test the hypothesis that urate-lowering therapy can reduce cardiovascular risk in these patients.

Related Articles

Prescription and comorbidity screening following consultation for acute gout in primary care
Rheumatology, 11/23/09    Relevance Score: 91%

Outcome Domains for Studies of Acute and Chronic Gout
Journal of Rheumatology, 10/20/09    Relevance Score: 91%

A survey on the management of gout in Malaysia
International Journal of Rheumatic Diseases, 11/25/09    Relevance Score: 89%

Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09    Relevance Score: 89%

Progress in Measurement Instruments for Acute and Chronic Gout Studies
Journal of Rheumatology, 10/23/09    Relevance Score: 88%

Today in Gout and Hyperuricemia...keeping you current

Crystal-induced neutrophil activation
Immunology & Cell Biology, 12/09/09

Common Polymorphisms Influencing Serum Uric Acid Levels Contribute to Susceptibility to Gout, but Not to Coronary Artery Disease
PLoS ONE - Cardiovascular Disorders, 11/10/09

The modern management of gout
Rheumatology, 10/08/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address